Helicobacter pylori eradication rates with concomitant and tailored therapy based on 23S rRNA point mutation: A multicenter randomized controlled trial

Nationwide antibiotic resistance mapping of Helicobacter pylori in Korea: A prospective multicenter study

(2019) Jeong Hoon Lee et al.   HELICOBACTER

Comparative study of Helicobacter pylori eradication rates of concomitant therapy vs modified quadruple therapy comprising proton-pump inhibitor, bismuth, amoxicillin, and metronidazole in Korea

(2018) Jung Wan Choe et al.   HELICOBACTER

Seroprevalence of Helicobacter pylori in Korea: A multicenter, nationwide study conducted in 2015 and 2016

(2018) Jeong Hoon Lee et al.   HELICOBACTER

Systematic review with meta-analysis: Vonoprazan, a potent acid blocker, is superior to proton-pump inhibitors for eradication of clarithromycin-resistant strains of Helicobacter pylori

(2018) Min Li et al.   HELICOBACTER

Clinical relevance of point mutations in the 23S rRNA gene in Helicobacter pylori eradication

(2018) Chang-Geun Park et al.   MEDICINE

Helicobacter pylori eradication rates of concomitant and sequential therapies in Korea

(2017) Seung Young Kim et al.   HELICOBACTER

Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report

(2016) P Malfertheiner et al.   GUT

Online Registry for Nationwide Database of Current Trend ofHelicobacter pyloriEradication in Korea: Interim Analysis

(2016) Beom Jin Kim et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial

(2016) Jyh-Ming Liou et al.   LANCET

Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-lineHelicobacter pyloritherapy

(2015) Wei Zhang et al.   GUT

The Diagnostic Validity of Citric Acid-Free, High Dose13C-Urea Breath Test AfterHelicobacter pyloriEradication in Korea

(2015) Yong Hwan Kwon et al.   HELICOBACTER

Sequential or concomitant therapy for eradication ofHelicobacter pyloriinfection: A systematic review and meta-analysis

(2015) Joon Sung Kim et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Guidelines for the diagnosis and treatment ofHelicobacter pyloriinfection in Korea, 2013 revised edition

(2014) Sang Gyun Kim et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Clarithromycin-Based Standard Triple Therapy Can Still Be Effective for Helicobacter pylori Eradication in Some Parts of the Korea

(2014) Kyu-Hyun Yoon et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Dual-priming oligonucleotide-based multiplex PCR using tissue samples in rapid urease test in the detection ofHelicobacter pyloriinfection

(2014) Woo Chul Chung   WORLD JOURNAL OF GASTROENTEROLOGY

Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence

(2013) David Y. Graham et al.   Clinical Gastroenterology and Hepatology

Ten day sequential versus 10 day modified bismuth quadruple therapy as empirical firstline and secondline treatment forHelicobacter pyloriin Chinese patients: an open label, randomised, crossover trial

(2013) Kevin S H Liu et al.   GUT

Eradication of Helicobacter pylori According to 23S Ribosomal RNA Point Mutations Associated With Clarithromycin Resistance

(2013) H. J. Lee et al.   JOURNAL OF INFECTIOUS DISEASES

Comparative proteomics analysis of sarcosine insoluble outer membrane proteins from clarithromycin resistant and sensitive strains of Helicobacter pylori

(2013) Rebecca Smiley et al.   JOURNAL OF MICROBIOLOGY

Prevalence of Primary and Secondary Antimicrobial Resistance ofHelicobacter pyloriin Korea from 2003 through 2012

(2012) Jung Won Lee et al.   HELICOBACTER

Helicobacter pylori Eradication Therapy Research: Ethical Issues and Description of Results

(2010) David Y. Graham   Clinical Gastroenterology and Hepatology

Helicobacter pylori treatment in the era of increasing antibiotic resistance

(2010) D. Y. Graham et al.   GUT

Bismuth-Containing Quadruple Therapy as Second-Line Treatment forHelicobacter pyloriInfection: Effect of Treatment Duration and Antibiotic Resistance on the Eradication Rate in Korea

(2010) Byoung Hwan Lee et al.   HELICOBACTER

Guidelines for the Management ofHelicobacter pyloriInfection in Japan: 2009 Revised Edition

(2010) Masahiro Asaka et al.   HELICOBACTER

Contribution of efflux pumps to clarithromycin resistance in Helicobacter pylori

(2010) Kenro Hirata et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Clarithromycin-Resistant Genotypes and Eradication of Helicobacter Pylori

(2010) Ruggiero Francavilla et al.   JOURNAL OF PEDIATRICS